US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist

0.501
+0.014+2.94%

Trading Dec 12 11:56 ET

20.79MMarket Cap-0.52P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
Aug 8, 2024	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

Aug 8, 20242024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Cognition Therapeutics Earnings Reports

Cognition Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 07:48 ET

Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

Nov 13 07:43 ET

Cognition Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:19 ET

Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update

Aug 8 07:14 ET

Analyst Rating

Updated: Dec 12, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall